Brief: Proteomics International Laboratories Signs Exclusive Licence Agreement With Sonic Healthcare USA
May 10 (Reuters) - Proteomics International Laboratories
Ltd PIQ.AX :
* SIGNED AN EXCLUSIVE LICENCE AGREEMENT WITH SONIC
HEALTHCARE USA
* LICENCE AGREEMENT FOR USE AND COMMERCIALISATION OF
PROMARKERD
PREDICTIVE TEST IN UNITED STATES
Source text for Eikon: ID:nASX34MV7n
Further company coverage: PIQ.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Proteomics International Laboratories
See all newsBrief: Proteomics International Laboratories Launches Share Purchase Plan To Raise Up To A$5 MLN
Australia's Proteomics slips to four-month low on discounted share sale plan
Brief: Proteomics International Laboratories Posts FY Loss Attributable A$8.6 Million
Brief: Proteomics International Laboratories Signs Agreement With Healius For Promarker Portfolio
Australia's Proteomics International soars on distribution deal with Healius